Elucidating the exact pharmacological mechanism of action (MOA) of Normally transpiring compounds can be complicated. Despite the fact that Tarselli et al. (60) developed the primary de novo synthetic pathway to conolidine and showcased that this Obviously occurring compound proficiently suppresses responses to each chemically induced and inflammat